CA-19-9 AND CEA IN THE DIFFERENTIAL-DIAGNOSIS OF ISOLATED LIVER METASTASES COMPARED TO CLINICAL LABORATORY TESTS

被引：0
|
作者：
LORENZ, M
HOTTENROTT, C
BAUM, RP
MAUL, FD
KIRKOWAREIMANN, M
HOR, G
ENCKE, A
机构：
来源：
NUCLEAR MEDICINE COMMUNICATIONS | 1987年 / 8卷 / 10期
关键词：
D O I：
10.1097/00006231-198710000-00004
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：787 / 796
页数：10
相关论文
共 50 条
  • [21] SERIAL LEVELS OF MONOCLONAL-ANTIBODY CA-19-9 IN COLONIC-CANCER AND BENIGN LIVER-DISEASE - COMPARISON WITH CEA
    NOVIS, BH
    GLUCK, E
    THOMAS, P
    STEELE, G
    ZAMCHECK, N
    GASTROENTEROLOGY, 1985, 88 (05) : 1519 - 1519
  • [22] CEA, CA 19-9, and CA 125 in the differential diagnosis of benign and malignant pancreatic diseases with or without jaundice
    Duraker, Nuevit
    Hot, Semih
    Polat, Yuecel
    Hoebek, Anil
    Gencler, Nur
    Urhan, Nuray
    JOURNAL OF SURGICAL ONCOLOGY, 2007, 95 (02) : 142 - 147
  • [23] TUMOR-MARKER SECRETION (CA-19-9, CEA, CA-125) BY XENOGRAFTS OF 8 DIFFERENT HUMAN PANCREATIC CARCINOMAS COMPARED TO THE HUMAN-TUMORS
    KLAPDOR, R
    HARMS, F
    BAHLO, M
    ARPS, H
    DIETEL, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 1989, 165 (07): : 496 - 497
  • [24] CONTRIBUTION OF THE CA 19-9-TEST IN THE DIFFERENTIAL-DIAGNOSIS OF CHRONIC-PANCREATITIS AND CANCER OF THE PANCREAS
    VANGOSSUM, M
    DELANGHE, A
    GERARD, M
    DELCOURT, A
    DELTENRE, M
    ACTA GASTRO-ENTEROLOGICA BELGICA, 1987, 50 (01): : 91 - 94
  • [25] CA 19-9 IN THE DIFFERENTIAL-DIAGNOSIS BETWEEN PANCREATIC-CANCER AND CHRONIC-PANCREATITIS
    FARINI, R
    FABRIS, C
    BONVICINI, P
    PICCOLI, A
    DELFAVERO, G
    VENTURINI, R
    PANUCCI, A
    NACCARATO, R
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (04): : 429 - 432
  • [26] The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer
    Ni, XG
    Bai, XF
    Mao, YL
    Shao, YF
    Wu, JX
    Shan, Y
    Wang, CF
    Wang, J
    Tian, YT
    Liu, Q
    Xu, DK
    Zhao, P
    EJSO, 2005, 31 (02): : 164 - 169
  • [27] DIFFERENTIAL-DIAGNOSIS OF PANCREATIC DISEASES USE OF TUMOR-MARKER (CA 19-9,CEA,POA800,AFP)DETERMINATIONS IN PANCREATIC JUICES AND SERA
    SCHMIEGEL, WH
    EBERL, W
    KREIKER, C
    ARNDT, R
    CLASSEN, M
    GRETEN, H
    JESSEN, K
    KALTHOFF, H
    KLAPDOR, R
    SOEHENDRA, N
    THIELE, HG
    GASTROENTEROLOGY, 1984, 86 (05) : 1236 - 1236
  • [28] CA 19-9 ASSAY IN DIFFERENTIAL-DIAGNOSIS OF PANCREATIC-CARCINOMA FROM INFLAMMATORY PANCREATIC DISEASES
    PIANTINO, P
    ANDRIULLI, A
    GINDRO, T
    PECCHIO, F
    MASOERO, G
    CAVALLINI, G
    NACCARATO, R
    DOBRILLA, G
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1986, 81 (06): : 436 - 439
  • [29] VALUE OF CA 19-9 IN THE DIFFERENTIAL-DIAGNOSIS BETWEEN PANCREATIC-CARCINOMA AND CHRONIC-PANCREATITIS
    SAFI, F
    BITTNER, R
    ROSCHER, R
    BEGER, HG
    DIGESTION, 1985, 32 (03) : 214 - 214
  • [30] Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer
    Ychou, M
    Duffour, J
    Kramar, A
    Gourgou, S
    Grenier, J
    DISEASE MARKERS, 2000, 16 (3-4) : 105 - 110
12345